REFERENCES
1. Bustamante J. Mendelian susceptibility to mycobacterial disease:
recent discoveries. Hum Genet. 2020.
2. Alodayani AN, Al-Otaibi AM, Deswarte C, Frayha HH, Bouaziz M,
AlHelale M, et al. Mendelian Susceptibility to Mycobacterial Disease
Caused by a Novel Founder IL12B Mutation in Saudi Arabia. J Clin
Immunol. 2018;38(3):278-82.
3. Patel NC, Minifee PK, Dishop MK, Munoz FM. Mycobacterium simiae
cervical lymphadenitis. Pediatr Infect Dis J. 2007;26(4):362-3.
4. Coolen-Allou N, Touron T, Belmonte O, Gazaille V, Andre M, Allyn J,
et al. Clinical, Radiological, and Microbiological Characteristics of
Mycobacterium simiae Infection in 97 Patients. Antimicrob Agents
Chemother. 2018;62(7).
5. Hamieh A, Tayyar R, Tabaja H, S ELZ, Bou Khalil P, Kara N, et al.
Emergence of Mycobacterium simiae: A retrospective study from a tertiary
care center in Lebanon. PLoS One. 2018;13(4):e0195390.
6. Varghese B, Enani M, Shoukri M, AlJohani S, AlThawadi S, Al-Hajoj S.
Burden of non-tuberculous mycobacterial diseases in Saudi Arabian
children: The first nationwide experience. J Infect Public Health.
2019;12(6):803-8.
7. Hashemi-Shahraki A, Darban-Sarokhalil D, Heidarieh P, Feizabadi MM,
Deshmir-Salameh S, Khazaee S, et al. Mycobacterium simiae: a possible
emerging pathogen in Iran. Jpn J Infect Dis. 2013;66(6):475-9.
8. de Beaucoudrey L, Samarina A, Bustamante J, Cobat A, Boisson-Dupuis
S, Feinberg J, et al. Revisiting human IL-12Rbeta1 deficiency: a survey
of 141 patients from 30 countries. Medicine (Baltimore).
2010;89(6):381-402.
9. Martinez-Barricarte R, Megged O, Stepensky P, Casimir P,
Moncada-Velez M, Averbuch D, et al. Mycobacterium simiae infection in
two unrelated patients with different forms of inherited IFN-gammaR2
deficiency. J Clin Immunol. 2014;34(8):904-9.
10. Braue J, Murugesan V, Holland S, Patel N, Naik E, Leiding J, et al.
NF-kappaB Essential Modulator Deficiency Leading to Disseminated
Cutaneous Atypical Mycobacteria. Mediterr J Hematol Infect Dis.
2015;7(1):e2015010.